Latest News for: Wamd

Edit

Aflibercept 8 mg Meets Primary Endpoints in Two Global Pivotal Trials for DME and wAMD, with a Vast Majority of Patients Maintained on 12- and 16-week Dosing Intervals

PR Newswire 08 Sep 2022
79% and 77% of wet age-related macular degeneration (wAMD) patients were rapidly initiated and maintained on 12- and 16-week dosing intervals (without need for regimen modification) through week 48, respectively ... PULSAR (wAMD).
Edit

Aflibercept 8 mg Meets Primary Endpoints in Two Global Pivotal Trials for DME and wAMD, ...

The Associated Press 08 Sep 2022
79% and 77% of wet age-related macular degeneration (wAMD) patients were rapidly initiated and maintained on 12- and 16-week dosing intervals (without need for regimen modification) through week 48, respectively ... PULSAR (wAMD) ... About DME and wAMD.
Edit

Replay KOL Webcast: Christian Pruente on wAMD and KIN001 (Kinarus Therapeutics Holding AG)

Public Technologies 28 Jun 2022
). The text version of this document is not available ... Disclaimer ... (noodl. 62197168) .
Edit

Live KOL Webcast: Christian Pruente on wAMD and KIN001 (Kinarus Therapeutics Holding AG)

Public Technologies 27 Jun 2022
). The text version of this document is not available ... Disclaimer ... (noodl. 62180751) .
  • 1
×